Sign in
4

Changes in Ownership

PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-25-118545

President and CEO sold 7,040 shares at an average $41.00 ($288,607)

  • President and CEO acquired 30,000 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENDHEIM JACK · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-03 Conversion : show line 1 in the form 10b5-1 +30,000 56,800 I
2025-12-03 Sale : show line 2 in the form 10b5-1 −3,520 $40.77 $143,511 53,280 I
2025-12-04 Sale : show line 3 in the form 10b5-1 −3,152 $41.16 $129,731 50,128 I
2025-12-04 Sale : show line 4 in the form 10b5-1 −368 $41.75 $15,365 49,760 I
Open-market sales · 7,040 sh · avg $41.00 · $288,607

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-03 Conversion : show line 5 in the form 10b5-1 Class B Common Stock −30,000 19,961,034 I
Loading xslF345X05/tm2532723-1_4seq1.xml…